ASCO Annual Meeting | June 3-7, 2022
Biond Biologics presented together with Sanofi at The ASCO 2022 Annual Meeting pre-clinical translational Data of SAR444881 (BND-22) at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting that took place in Chicago, Illinois, June 3-7, 2022.
The poster presented pre-clinical translational data including potential patient enrichment biomarkers for SAR444881 (BND-22) a first-in-class anti-ILT2 monoclonal antibody for cancer immunotherapy.